Therefore, it is likely that the engagement of RET at the mucosal sites (i.e. intestinal mucosa) is able to activate the CCL20-CCR6 pathway and, therefore, participate in modulating the homeostasis of the gut associated lymphoid tissue (GALT) in response to infections. The gene discussed is RET; the disease is infection.